RecruitingNCT05011045

Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies


Sponsor

M.D. Anderson Cancer Center

Enrollment

100 participants

Start Date

Jan 9, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

This study assesses neurocognitive outcomes after receiving radiation therapy to the brain (whole brain radiation therapy) in patients with blood cancers (hematologic malignancies). This may help researchers learn more about the effects of whole brain radiation therapy on memory and thinking in patients with blood cancer.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study looks at how whole-brain radiation therapy affects thinking and memory in people treated for blood cancers that have spread to the brain, such as lymphoma or leukemia. Researchers want to understand the long-term effects on brain function. **You may be eligible if...** - You are 18 or older - You received radiation therapy to the brain for a blood cancer (such as lymphoma, leukemia, or myeloma) - You are able to complete cognitive tests in English - If you have claustrophobia or mild cognitive issues, you may still qualify if these are managed with medication **You may NOT be eligible if...** - You did not receive whole-brain radiation for a blood cancer - You are unable to complete the required cognitive tests - You have severe, unmanaged claustrophobia or cognitive impairment Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREMagnetic Resonance Imaging

Undergo MRI

OTHERNeurocognitive Assessment

Undergo neurocognitive function assessment

OTHERQuality-of-Life Assessment

Complete questionnaires

OTHERQuestionnaire Administration

Complete questionnaires


Locations(1)

M D Anderson Cancer Center

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05011045


Related Trials